Rockwell Medical, Inc.
RMTI
$0.95
$0.00-0.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.49% | 1.52% | -100.40% | -145.43% | 385.13% |
| Total Depreciation and Amortization | -3.37% | 4.45% | -0.74% | 0.00% | -1.09% |
| Total Amortization of Deferred Charges | 1.14% | 0.00% | -1.12% | 1.14% | 193.33% |
| Total Other Non-Cash Items | 1.79% | -21.51% | 15.75% | -13.68% | 60.79% |
| Change in Net Operating Assets | -161.25% | 147.91% | -74,860.00% | -99.40% | 544.44% |
| Cash from Operations | -170.88% | 152.88% | -503.12% | -79.77% | 196.46% |
| Capital Expenditure | -39.63% | -160.32% | 84.05% | -106.81% | 33.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,788.52% | -1.61% | -1.59% | 101.06% | -395.61% |
| Cash from Investing | -4,083.50% | -10,200.00% | 99.70% | 94.57% | -455.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -49.77% | 38.04% | -1.17% | -0.59% | -147.10% |
| Issuance of Common Stock | -- | -- | -- | 4.35% | 64.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -72.41% | 0.23% | 33.23% | 33.09% | -- |
| Cash from Financing | 1,137.54% | 16.99% | -128.04% | 20.71% | 12.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.39% | 125.54% | -228.49% | 599.79% | -90.90% |